Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 2020

View Archived Issues

iPSCs find best therapy for Best disease

Terns and Hansoh enter collaboration and license agreement for TRN-000632 in Greater China

Proof of concept seen with CAR T cells targeting chondroitin sulfate for treating bladder cancer

Bayer presents promising preclinical and phase I data for BAY-2433334

Novel mouse model of AAA with intraluminal thrombus

Kyorin Pharmaceutical discloses new 15-hydroxyprostaglandin dehydrogenase inhibitors

New MGAT2 inhibitors discovered at Shionogi

Incyte synthesizes new STING receptor agonists

Lilly discovers interleukin-17 receptor A antagonists

Genetic variant combination in MPIG6B and SH2B3 genes leads to myelofibrosis and thrombocytopenia

Astrogen identifies new serine derivatives

Screening in serum yields potential antibiotics against drug-resistant K. pneumoniae

Positive topline data presented from phase IIa ACTION study of DMX-200 in FSGS

Apogenix receives regulatory approval in Russia for phase II study of asunercept in COVID-19

Arrowhead initiates phase II study of AMG-890

First patient dosed in phase I/II study of RP-3500

Constant Therapeutics initiates phase II study of TXA-127 for COVID-19

Enterome begins clinical evaluation of cancer multipeptide therapeutic vaccine EO-2401

Phase I trial evaluates IBS therapy SMP-100 in healthy volunteers

INSPIRE trial of rigosertib reaches required survival events for data analysis

Noxopharm advances Veyonda for prostate cancer and COVID-19

ONC-392 moves into first-in-human study in advanced solid tumors and NSCLC

AL-001 normalizes progranulin levels in patients with GRN gene-mutation frontotemporal dementia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...